Chad Therapeutics Executive to Retire at End of Month

Chad Therapeutics has announced that Senior Vice President Frank Fleming will retire March 31.

The Chatsworth company said Fleming’s retirement had been planned since last year. No replacement has been named.

Fleming will become a consultant to the company, primarily in marketing, sales, and government and industry affairs.

Chad develops, manufactures and distributes oxygen-conserving devices and oxygen-delivery systems for home health-care patients who require supplemental oxygen.